Giant Cell Tumors
Showing 9976 - 10000 of >10,000
NSCLC Trial in NanCHang (V9, )
Recruiting
- Non-small Cell Lung Cancer
- V9
- placebo
-
NanCHang, Jiang XI, ChinaChunling Jiang
Oct 17, 2021
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)
Not yet recruiting
- Neurofibroma
- Neurofibroma, Plexiform
- Cryotherapy
- (no location specified)
Jan 19, 2022
Oral Complications After Haematopoietic Stem Cell
Enrolling by invitation
- Stem Cell Transplant Complications
- Oral Complication
- Haematopoietic stem cell transplantation
-
Nijmegen, NetherlandsRadboudumc
Oct 21, 2022
Knee Osteoarthritis Trial (INMUNOCEM, PLACEBO COMPARATOR)
Not yet recruiting
- Knee Osteoarthritis
- INMUNOCEM
- PLACEBO COMPARATOR
- (no location specified)
Jun 29, 2023
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)
Active, not recruiting
- Breast Cancer
- +4 more
- Nebivolol
- Placebo
-
Rozzano, Milan, ItalyIRCCS Humanitas Research Hospital
Feb 5, 2023
Head Neck Cancer Trial in Taichung, Taipei, Taoyuan (ASP-1929 Photoimmunotherapy)
Recruiting
- Head and Neck Cancer
- ASP-1929 Photoimmunotherapy
-
Taichung, Taiwan
- +4 more
Feb 22, 2022
Head and Neck Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab combined with Chemotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab combined with Chemotherapy
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Feb 4, 2022
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Recruiting
- Xeroderma Pigmentosum
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hodgkin Lymphoma Trial in Moscow (Nivolumab)
Recruiting
- Hodgkin Lymphoma
-
Moscow, Russian FederationNational Research Center for Hematology
Dec 13, 2022
NSCLC With EGFR Mutation, Locally Advanced Solid Tumor, Metastatic Cancer Trial in Shanghai (Osimertinib, Anlotinib)
Recruiting
- Non-Small Cell Lung Cancer With EGFR Mutation
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Chest hospital
Feb 24, 2021
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Anorexia Trial in Cairo (Olanzapine 5 MG, Placebo)
Recruiting
- Anorexia
- Olanzapine 5 MG
- Placebo
-
Cairo, EgyptKasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine
Feb 18, 2022
Small-cell Lung Cancer Trial in Shanghai (TQB2450)
Recruiting
- Small-cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jan 25, 2021
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Colorectal Tumors Trial in Shenzhen (Apatinib Mesylate Tablets, Bevacizumab Injection)
Recruiting
- Colorectal Neoplasms
- Apatinib Mesylate Tablets
- Bevacizumab Injection
-
Shenzhen, Guang Dong, ChinaShenzhen People's Hospital
Sep 26, 2021
Non-Squamous Non Small Cell Lung Cancer Trial in Changsha (Anlotinib and Docetaxel)
Recruiting
- Non-Squamous Non Small Cell Lung Cancer
- Anlotinib and Docetaxel
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 1, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,
Not yet recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +2 more
- CyPep-1
- Pembrolizumab 25 MG/ML [Keytruda]
-
Pittsburgh, Pennsylvania
- +18 more
Nov 21, 2022
Pancreatic Tumors Trial in Los Angeles (EUS with Fiducial)
Recruiting
- Pancreatic Neoplasms
- EUS with Fiducial
-
Los Angeles, CaliforniaLos Angeles County Hospital
Nov 16, 2021
Head Neck Cancer Trial in Cairo (Dose escalation, Standard dose)
Recruiting
- Head and Neck Cancer
- Dose escalation
- Standard dose
-
Cairo, EgyptNational Cancer Institute
Jun 15, 2021
Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance
Recruiting
- Brain Tumor Adult
- Hyperpolarized 13C-Pyruvate
- Gadolinium
-
Dallas, TexasUT Southwestern Medical Center
Apr 26, 2022
Virtual Reality, Education, Bladder Cancer Trial in Roskilde (Motor Imagery)
Active, not recruiting
- Virtual Reality
- +2 more
- Motor Imagery
-
Roskilde, Danmark, DenmarkUrology Department Zealand University Hospital
Aug 23, 2021